Roche said this week that William Burns will not stand for re-election to the board of directors. The company also said that it has proposed that Christoph Franz be elected as chairman of the board, and the remaining members of the board should be re-elected.
The remaining board members include Andre Hoffman; Andreas Oeri; Pius Baschera; John Irving Bell; Paul Bulcke; DeAnne Julius; Severin Schwan; Peter Voser; Arthur Levinson; and Beatrice Weder di Mauro.
The Personalized Medicine Coalition has appointed Steven Averbuch and Michael Kolodziek to seats on its board of directors.
Averbuch is VP of translational clinical diagnostic development and pharmacodiagnostics at Bristol-Myers Squibb and Kolodziek is national medical director of Oncology Solutions.
The two new members will join the board as the terms of Joanne Armstrong and Nancy Simonian expire at the end of 2013.